Wheatley D
Psychopharmacology Research Group, Cobham, Surrey.
Br J Psychiatry. 1992 Jul;161:113-5. doi: 10.1192/bjp.161.1.113.
Minaprine (200 mg daily, either once or divided b.d.) was compared with amitriptyline (25-50 mg t.d.s.) over six weeks in 144 patients with major depression. Significant reductions in HRSD scores at the end of six weeks' treatment were recorded with both dose regimes of minaprine and with amitriptyline, with no significant differences between them. There was a significantly greater incidence of drowsiness and dry mouth with amitriptyline than with minaprine.
在144例重度抑郁症患者中,将米那普明(每日200毫克,单次服用或分两次服用)与阿米替林(每日25 - 50毫克,分三次服用)进行了为期六周的比较。在六周治疗结束时,米那普明的两种剂量方案和阿米替林均使汉密尔顿抑郁量表(HRSD)评分显著降低,两者之间无显著差异。与米那普明相比,阿米替林导致嗜睡和口干的发生率显著更高。